TNS Healthcare launches DetailMed

TNS Healthcare has unveiled a call assessment tool measuring detail effectiveness across countries, brands and categories. According to a company statement, DetailMed is tracked continuously online, and allows users to monitor the quality of their own sales calls, as well as competitors' detailing. 
“DetailMed is the first continuous call assessment tool built to support global brands. With DetailMed, pharmaceutical companies finally have a solution that lets them measure message impact and call quality across countries—a strategic necessity for fully understanding and optimizing brand performance,” said David Owen, director at TNS Healthcare, in a statement.

Info gathered by DetailMed is presented through an online dashboard, a type of user interface increasingly used for tracking ROI. Users can customize the service by choosing the geographic level, frequency of results or specific physicians. 
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.